Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Cash & Equivalents (2016 - 2026)

Westlake Chemical Partners filings provide 12 years of Cash & Equivalents readings, the most recent being $44.3 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 24.09% to $44.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.3 million, a 24.09% decrease, with the full-year FY2025 number at $44.3 million, down 24.09% from a year prior.
  • Cash & Equivalents hit $44.3 million in Q4 2025 for Westlake Chemical Partners, up from $37.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $104.6 million in Q1 2023 to a low of $17.1 million in Q4 2021.
  • Median Cash & Equivalents over the past 5 years was $46.9 million (2025), compared with a mean of $44.5 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 443.77% in 2023 and later plummeted 46.69% in 2024.
  • Westlake Chemical Partners' Cash & Equivalents stood at $17.1 million in 2021, then skyrocketed by 279.8% to $64.8 million in 2022, then dropped by 9.51% to $58.6 million in 2023, then fell by 0.52% to $58.3 million in 2024, then decreased by 24.09% to $44.3 million in 2025.
  • The last three reported values for Cash & Equivalents were $44.3 million (Q4 2025), $37.9 million (Q3 2025), and $36.6 million (Q2 2025) per Business Quant data.